Made a 37% move after hours Friday on the launch of COVID19 program
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections....
BOTHELL, WA,, March 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage
Biotechnology company discovering and developing novel antiviral therapeutics, today announced it has initiated its Coronavirus program.
finance.yahoo.com
“Following our acquisition of patent rights and know-how from KSURF
and...
